These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23319035)

  • 101. Sequence variation of the HVR1 region of Hepatitis C virus in response to interferon-α and ribavirin treatment.
    Al-Qahtani AA; Rubino S; Al-Ahdal MN
    J Infect Dev Ctries; 2011 May; 5(5):370-6. PubMed ID: 21628814
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Hepatitis C virus subtypes circulating among intravenous drug users in Lisbon, Portugal.
    Calado RA; Rocha MR; Parreira R; Piedade J; Venenno T; Esteves A
    J Med Virol; 2011 Apr; 83(4):608-15. PubMed ID: 21328374
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy.
    Nicot F; Alric L; Barange K; Métivier S; Dramard JM; Combis JM; Castan B; Meurisse JJ; Payen JL; Garipuy D; Desmorat H; Peron JM; Thebault S; Morin T; Renou C; Barel P; Guerin B; Imbert Y; Sire S; Sauné K; Chatelut E; Izopet J
    J Med Virol; 2011 Mar; 83(3):437-44. PubMed ID: 21264864
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Molecular and epidemiological profiles of hepatitis C virus genotype 4 in Denmark.
    Eriksen MB; Jørgensen LB; Krarup H; Laursen AL; Christensen PB; Møller A; Schlichting P; Kuiken C; Bukh J; Weis N;
    J Med Virol; 2010 Nov; 82(11):1869-77. PubMed ID: 20872713
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy.
    Legrand-Abravanel F; Colson P; Leguillou-Guillemette H; Alric L; Ravaux I; Lunel-Fabiani F; Bouviers-Alias M; Trimoulet P; Chaix ML; Hézode C; Foucher J; Fontaine H; Roque-Afonso AM; Gassin M; Schvoerer E; Gaudy C; Roche B; Doffoël M; D'Alteroche L; Vallet S; Baazia Y; Pozzetto B; Thibault V; Nousbaum JB; Roulot D; Coppere H; Poynard T; Payan C; Izopet J
    J Med Virol; 2009 Dec; 81(12):2029-35. PubMed ID: 19856464
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Emergence of hepatitis C virus genotype 4: phylogenetic analysis reveals three distinct epidemiological profiles.
    de Bruijne J; Schinkel J; Prins M; Koekkoek SM; Aronson SJ; van Ballegooijen MW; Reesink HW; Molenkamp R; van de Laar TJ
    J Clin Microbiol; 2009 Dec; 47(12):3832-8. PubMed ID: 19794040
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Genetic variability of hepatitis C virus in South Egypt and its possible clinical implication.
    Elkady A; Tanaka Y; Kurbanov F; Sugauchi F; Sugiyama M; Khan A; Sayed D; Moustafa G; Abdel-Hameed AR; Mizokami M
    J Med Virol; 2009 Jun; 81(6):1015-23. PubMed ID: 19382263
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Predictors of sustained virological response to a 48-week course of pegylated interferon alfa-2a and ribavirin in patients infected with hepatitis C virus genotype 4.
    Al Ashgar H; Helmy A; Khan MQ; Al Kahtani K; Al Quaiz M; Rezeig M; Kagevi I; Alshehri A; Al Kalbani A; Al Swat K; Dahab S; Elkum N; Al Fadda M
    Ann Saudi Med; 2009; 29(1):4-14. PubMed ID: 19139619
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Hepatitis C virus infections reported over 11 years of surveillance in Saudi Arabia.
    Madani TA
    Trans R Soc Trop Med Hyg; 2009 Feb; 103(2):132-6. PubMed ID: 18789464
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Evaluation of Versant hepatitis C virus genotype assay (LiPA) 2.0.
    Verbeeck J; Stanley MJ; Shieh J; Celis L; Huyck E; Wollants E; Morimoto J; Farrior A; Sablon E; Jankowski-Hennig M; Schaper C; Johnson P; Van Ranst M; Van Brussel M
    J Clin Microbiol; 2008 Jun; 46(6):1901-6. PubMed ID: 18400913
    [TBL] [Abstract][Full Text] [Related]  

  • 111. High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland.
    Chlabicz S; Flisiak R; Kowalczuk O; Wiercińska-Drapalo A; Pytel-Krolczuk B; Prokopowicz D; Chyczewski L
    J Med Virol; 2008 Apr; 80(4):615-8. PubMed ID: 18297715
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Epidemiological characteristics and response to peginterferon plus ribavirin treatment of hepatitis C virus genotype 4 infection.
    Roulot D; Bourcier V; Grando V; Deny P; Baazia Y; Fontaine H; Bailly F; Castera L; De Ledinghen V; Marcellin P; Poupon R; Bourlière M; Zarski JP; Roudot-Thoraval F;
    J Viral Hepat; 2007 Jul; 14(7):460-7. PubMed ID: 17576387
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma.
    Abdel-Hamid M; El-Daly M; Molnegren V; El-Kafrawy S; Abdel-Latif S; Esmat G; Strickland GT; Loffredo C; Albert J; Widell A
    J Gen Virol; 2007 May; 88(Pt 5):1526-1531. PubMed ID: 17412982
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Genotyping of hepatitis C virus isolates from Saudi patients by analysis of sequences from PCR-amplified core region of the virus genome.
    Al-Ahdal MN; Rezeig MA; Kessie G
    Ann Saudi Med; 1997 Nov; 17(6):601-4. PubMed ID: 17338004
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to C/E1 and 5' untranslated region sequences.
    Murphy DG; Willems B; Deschênes M; Hilzenrat N; Mousseau R; Sabbah S
    J Clin Microbiol; 2007 Apr; 45(4):1102-12. PubMed ID: 17287328
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Hepatitis C virus genotyping by polymerase chain reaction and DNA enzyme immunoassay among Saudi patients in the Western Province, Saudi Arabia.
    Osoba AO; Ibrahim M; Abdelaal MA; Al-Mowallad A; Al Shareef B; Hussein BA
    Ann Saudi Med; 2000; 20(5-6):394-7. PubMed ID: 17264630
    [TBL] [Abstract][Full Text] [Related]  

  • 117. High prevalence of hepatitis C virus subtypes 4c and 4d in Malaga (Spain): phylogenetic and epidemiological analyses.
    Fernández-Arcás N; López-Siles J; Trapero S; Ferraro A; Ibáñez A; Orihuela F; Maldonado J; Alonso A
    J Med Virol; 2006 Nov; 78(11):1429-35. PubMed ID: 16998884
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Analysis of the 5' noncoding region versus the NS5b region in genotyping hepatitis C virus isolates from blood donors in France.
    Cantaloube JF; Laperche S; Gallian P; Bouchardeau F; de Lamballerie X; de Micco P
    J Clin Microbiol; 2006 Jun; 44(6):2051-6. PubMed ID: 16757597
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Sexually transmitted acute infection with a clustered genotype 4 hepatitis C virus in HIV-1-infected men and inefficacy of early antiviral therapy.
    Serpaggi J; Chaix ML; Batisse D; Dupont C; Vallet-Pichard A; Fontaine H; Viard JP; Piketty C; Rouveix E; Rouzioux C; Weiss L; Pol S
    AIDS; 2006 Jan; 20(2):233-40. PubMed ID: 16511416
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Molecular epidemiology of hepatitis C virus (HCV) in Greece: temporal trends in HCV genotype-specific incidence and molecular characterization of genotype 4 isolates.
    Katsoulidou A; Sypsa V; Tassopoulos NC; Boletis J; Karafoulidou A; Ketikoglou I; Tsantoulas D; Vafiadi I; Hatzis G; Skoutelis A; Akriviadis E; Vasiliadis T; Kitis G; Magiorkinis G; Hatzakis A
    J Viral Hepat; 2006 Jan; 13(1):19-27. PubMed ID: 16364078
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.